title: Association between clozapine-induced agranulocytosis and HLA subtyping.
authors.forename: Pilar
authors.initials: P
authors.lastname: Lopez-Garcia
authors.forename: Juana
authors.initials: J
authors.lastname: Teresa Rodriguez
authors.forename: Pilar
authors.initials: P
authors.lastname: De Castro
authors.forename: Ignacio
authors.initials: I
authors.lastname: Landecho
authors.forename: Ricardo
authors.initials: R
authors.lastname: Zapata
mesh_terms: D000380:Agranulocytosis / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006650:Histocompatibility Testing / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction / Q000706:statistics & numerical data; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy* / Q000276:immunology; D012565:Schizophrenic Psychology; D012569:Schizotypal Personality Disorder / Q000523:psychology
chemical_list: D014150:Antipsychotic Agents; D016179:Granulocyte Colony-Stimulating Factor; D003024:Clozapine